Ottobock has strengthened its position in the global prosthetics market with the acquisition a US company – its second acquisition this year.
The US company BionX Medical Technologies manufacturers the world’s only active prosthetic foot and ankle solution available in the market – the emPOWER Ankle.
The acquisition has allowed Ottobock to further expand its portfolio of mechatronic prosthetic feet.
It is the second new addition to Ottobock this year after it acquired the BeBionic hand in January.
“Innovations are our key growth driver. Combining the know-how of Ottobock and BionX is a crucial step towards reaching goals such as the intuitive prosthetic leg more quickly,” said Professor Hans Georg Näder, president of Otto Bock HealthCare GmbH.
“With the products we have acquired, both in upper limb and lower limb prosthetics, we will offer even more comprehensive fitting solutions in the future and therefore even better Quality for Life in the interest of our users. We are also promoting constructive networking with innovative minds at the Massachusetts Institute of Technology (MIT), and are already working on the joint further development of existing ideas with the BionX team,” Professor Hans Georg Näder continued.
BionX company founder and inventor of the first generation of the emPOWER Ankle, Hugh Herr, is also a Professor at MIT where he directs the Center for Extreme Bionics. Herr is considered one of the world leaders in the field of high-tech research. The headquarters and production facility of BionX are located in the Boston area as well. Ottobock is moving closer to the Boston research community with the acquisition.
Dr Herr said: “I am certain that this transaction constitutes an important step towards shaping the future of bionic prostheses by combining Ottobock’s proven track record of setting standards of care for amputees with BionX’s groundbreaking product and innovation capabilities.”